Rare Disease News

NORD Issues Statement on House’s Approval of 21st Century Cures Initiative

Published July 10, 2015 by NORD

Categorized in -

Advocacy

Washington, D.C. – July 10, 2015 – The following statement was issued by Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), on today’s approval …

Continue reading “NORD Issues Statement on House’s Approval of 21st Century Cures Initiative”

Impact of the Orphan Drug Tax Credit on Treatments for Rare Diseases

Published June 17, 2015 by NORD

Categorized in -

Today, the National Organization for Rare Disorders (NORD), Biotechnology Industry Organization (BIO), and Ernst & Young released “Impact of the Orphan Drug Tax Credit on Treatments for Rare Diseases,” …

Continue reading “Impact of the Orphan Drug Tax Credit on Treatments for Rare Diseases”

NORD Submits Final Comments on 21st Century Cures Act

Published June 3, 2015 by NORD

Categorized in -

Advocacy

NORD has finalized its comments on 21st Century Cures Act. Read them here: NORD Comments on the 21st Century Cures Act.

Global Voice for Rare Disease Patients Launches Today: Rare Diseases International

Published May 28, 2015 by NORD

Categorized in -

Madrid and Washington, D.C.—May 28, 2015—The global voice for rare disease patients launches today. More than 60 patient representatives from 30 countries are gathering in Madrid, …

Continue reading “Global Voice for Rare Disease Patients Launches Today: Rare Diseases International”

NORD Issues Statement on Today’s Approval of the 21st Century Cures Initiative

Published May 21, 2015 by NORD

Categorized in -

NORD President and CEO Peter L. Saltonstall today issued the following statement on the approval by the House Energy and Commerce Committee of the 21st Century Cures legislative initiative and …

Continue reading “NORD Issues Statement on Today’s Approval of the 21st Century Cures Initiative”

FDA Public Meeting on Chagas Disease Patient-Focused Drug Development

Published April 28, 2015 by NORD

Categorized in -

Advocacy

Paul Melmeyer, NORD’s Assistant Director of Public Policy, attended the FDA’s public meeting on Chagas Disease Patient-Focused Drug Development on April 28. Chagas is a rare parasitic disease (read NORD’s …

Continue reading “FDA Public Meeting on Chagas Disease Patient-Focused Drug Development”

The Will to Live and the Strength for a Cure

Published December 23, 2014 by NORD

Categorized in -

The day Joshua Frase was born, his parents Alison and Paul, were given grave news about their newborn’s life

Saving Eliza

Published December 23, 2014 by NORD

Categorized in -

I’m honored to be speaking at the NORD Breakthrough Summit on Rare Diseases and Orphan Products in October

Multiple Endocrine Neoplasia Type 1: One Family’s Fight

Published December 23, 2014 by NORD

Categorized in -

Vanessa Devore’s father, Octavio Armenta was never diagnosed, and neither was her grandfather. Hailing from Guadalajara, Mexico, she represents a legacy of fighters against an unknown disease, as the pioneer in her …

Continue reading “Multiple Endocrine Neoplasia Type 1: One Family’s Fight”

Taking Action for ACD

Published December 23, 2014 by NORD

Categorized in -

On February 20th, 2013, Eliza and John Rista of Huntersville, North Carolina were blessed with an uncomplicated pregnancy, and a healthy, full-term baby boy weighing 8 pounds and 6 ounces. …

Continue reading “Taking Action for ACD”

Rare Disease News

Access State Report Card Data